Attached files

file filename
EX-10.20 - EX-10.20 - ALIMERA SCIENCES INCg20643a6exv10w20.htm
EX-10.19 - EX-10.19 - ALIMERA SCIENCES INCg20643a6exv10w19.htm
EX-10.26 - EX-10.26 - ALIMERA SCIENCES INCg20643a6exv10w26.htm
EX-10.23 - EX-10.23 - ALIMERA SCIENCES INCg20643a6exv10w23.htm
S-1/A - FORM S-1/A - ALIMERA SCIENCES INCg20643a6sv1za.htm
Exhibit 5.1
April 20, 2010
Alimera Sciences, Inc.
6120 Windward Parkway, Suite 290
Alpharetta, GA 30005
           Re:   Registration Statement on Form S-1
Ladies and Gentlemen:
          We have examined the Registration Statement on Form S-1 (File No. 333-162782) originally filed by Alimera Sciences, Inc. (the “Company”) with the Securities and Exchange Commission (the “Commission”) on October 30, 2009, as thereafter amended or supplemented (the “Registration Statement”), in connection with the registration under the Securities Act of 1933, as amended, of up to 6,900,000 shares of the Company’s Common Stock (the “Shares”). The Shares, which include an over-allotment option granted by the Company to the Underwriters to purchase up to 900,000 additional shares of the Company’s Common Stock, are to be sold to the Underwriters by the Company and the selling stockholders as described in the Registration Statement. As your counsel in connection with this transaction, we have examined the proceedings taken and are familiar with the proceedings proposed to be taken by you in connection with the sale and issuance of the Shares.
     It is our opinion that, upon completion of the proceedings being taken or contemplated to be taken prior to the sale of the Shares, the Shares being sold by the Company and the selling stockholders, when issued and sold in the manner described in the Registration Statement and, with respect to the Shares being sold by the Company, in accordance with the resolutions adopted by the Board of Directors of the Company, will be legally and validly issued, fully paid and non-assessable.
     We consent to the use of this opinion as an exhibit to said Registration Statement, and further consent to the use of our name wherever appearing in said Registration Statement, including the prospectus constituting a part thereof, and in any amendment or supplement thereto.
          This opinion may be used only in connection with the offer and sale of the Securities while the Registration Statement is in effect.
Very truly yours,
/s/ Gunderson Dettmer Stough Villeneuve
Franklin & Hachigian, LLP